Fertility drug delivery study pulled before it began
NCT ID NCT07152730
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study was designed to see how a hormone called GnRH is processed by the body when given through a small pump (OmniPod) instead of a needle. It was meant for healthy women aged 18 to 40 with regular periods. However, the trial was withdrawn before any participants were enrolled, so no information was gathered.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lutrepulse (gonadotropin-releasing hormone)
- What this could lead to
- If successful, this could help develop a more convenient way to deliver GnRH for women with certain types of infertility.
- What could go wrong
- The trial was withdrawn before enrolling anyone, so no data were collected. It is very early-stage research with no results yet.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMENORRHEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ferring Investigational Site
Miami, Florida, 33172, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 'Abnormal' embryos still lead to healthy pregnancies? a new registry investigates
- Building a biological treasure trove to decode Women's health mysteries
- Can a glowing dye reveal a Woman's fertility after ovarian cyst surgery?
- Can a sperm 'Quality Check' boost IVF success?
- COVID-19's hidden presence: could the virus lurk in sperm?
- Can a daily supplement boost fertility? a new trial investigates